Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.

Item

http://www.wikidata.org/entity/Q40674993

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.

@en

type

Item

label

Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.

@en

prefLabel

Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.

@en

P1476

Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.

@en

P2093

Ann A Jakubowski

http://www.w3.org/2001/XMLSchema#string

Dick Chung

http://www.w3.org/2001/XMLSchema#string

Esperanza Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Hugo Castro-Malaspina

http://www.w3.org/2001/XMLSchema#string

Julia Foldi

http://www.w3.org/2001/XMLSchema#string

Miguel-Angel Perales

http://www.w3.org/2001/XMLSchema#string

Molly Maloy

http://www.w3.org/2001/XMLSchema#string

Seong Jin Kim

http://www.w3.org/2001/XMLSchema#string

Sergio A Giralt

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions of cytomegalovirus infection and disease in transplant recipients

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.

Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus

T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy.

Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer

Cytomegalovirus in hematopoietic stem cell transplant recipients

Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients

Live (vaccines) from New York.

P304

1480-1486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2016.05.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Genovefa Anna Papanicolaou

Yao-Ting Huang

D Neofytos

P577

2016-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27178374

http://www.w3.org/2001/XMLSchema#string

P932

4949094

http://www.w3.org/2001/XMLSchema#string